Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 6, 2008, Pages 667-672

  Kavallaris, Andreas ^a   Camara, Oumar ^a   Runnebaum, Ingo B ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Blue dye; Breast cancer; Sentinel lymph node mapping; Subareolar injection

Indexed keywords

DISULFINE BLUE; RADIOACTIVE MATERIAL;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; COLLOID; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; NUCLEAR MEDICINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INJECTIONS; LYMPH NODE EXCISION; MASTECTOMY; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 41849131492     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0333-7     Document Type: Article

References (44)

1. Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822
2. Anderson BO, Shyyan R, Eniu A, Smith RA, Yip C-H, Bese NS, Chow LWC, Masood S, Ramsey SD, Carlson RW (2006) Breast cancer in limited-resource countries: an overview of the breast health global initiative 2005 guidelines. Breast J 12(Suppl 1):S3-S15
3. Barnwell JM, Arredondo MA, Kollmorgen D et al (1998) Sentinel node biopsy in breast cancer. Ann Surg Oncol 5:126-130
4. Bass SS, Cox CE, Ku NN, Berman C, Reintgen DS (1999) The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 189:183-194
5. Bauer TW, Spitz FR, Callans LS, Alavi A, Mick R, Weinstein SP, Bedrosian I, Fraker DL, Bauer TL, Czerniecki BJ (2002) Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 9(2):169-176
6. Bauerfeind I, Himsl I, Kuhn T, Untch M, Hepp H (2004) Sentinel lymph node biopsy in breast cancer: state of the art. Gynakol Geburtshilfliche Rundsch 44(2):84-91. (Review, German)
7. Beller F (1990) Development and anatomy of the breast. In: Mitchell G, Bassett L (eds) The female breast and its disorders. Williams & Wilkins, Baltimore, pp 1-2
8. Boolbol SK, Fey JV, Borgen PI et al (2001) Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 8:20-24
9. Borgstein PJ, Meijer S, Pijpers R (1997) Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 349:1668-1669
10. Borgstein PJ, Pijpers R, Comans EF, Van Diest PJ, Boom RP, Meijer S (1998) Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283
11. Borgstein PJ, Meijer S, Pijpers RJ, Van Diest PJ (2000) Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg 232:81-89
12. Chagpar A, Martin RC III, Chao C, Wong SL, Edwards MJ, Tuttle T, McMasters KM (2004) Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 139(6):614-618
13. Edwards MJ, Giuliano A, Reintgen D et al (2000) Consensus statement on sentinel lymph node biopsy: guidelines for performance of sentinel lymph node biopsy for breast cancer. American Society of Breast Surgeons. Accessed 30 October, 2001. http://www.breastsurgeons.org/sentinel.htm
14. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765-772
15. Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401
16. Grant RN, Tabah EJ, Adair FE (1953) The surgical significance of the subareolar lymph plexus in cancer of the breast. Surgery 33:71-78
17. Gray J (1939) The relation of the lymphatic vessels to the spread of cancer. Br J Cancer 26:462-495
18. Guenther JM, Krishnamoorthy M, Tan LR (1997) Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3:336-340
19. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136-138
20. Kern KA (1999) Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 189:539-545
21. Kern KA, Rosenberg RJ (2000) Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99 m sulfur colloid. J Am Coll Surg 191:479-489
22. Kissin MW, Querci della Rovere G, Easton E, Westbury G (1986) Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:580-584
23. Klimberg VS, Rubio IT, Henry R, Cowan C, Colvert M, Korourian S (1999) Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 229:860-864
24. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-339
25. Kuhn T, Kreienberg R (2004) Sentinel node biopsy in breast cancer. German Society for Senology defines quality standards. Dtsch Med Wochenschr 129(8):387-390. (Review)
26. Linehan DC, Hill AD, Akhurst T et al (1999) Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6:450-454
27. Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS III, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP (2005) American society of clinical oncology guideline: recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720
28. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98(9):599-609
29. McMasters KM, Wong SL, Martin RC et al (2001) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233:676-687
30. Mertz L, Mathelin C, Marin C et al (1999) Subareolar injection of 99 m-Tc sulfur colloid for sentinel node identification in multifocal invasive breast cancer. Bull Cancer 86:939-945
31. Morton DL, Duan-Ren W, Wong JH (1992) Technical details of intraoperative lymphatic mapping and sentinel node biopsy in the management of primary melanoma. Arch Surg 127:392-399
32. NIH Consensus Conference (1991) Treatment of early-stage breast cancer. JAMA 265:391-395
33. O'Hea BJ, Hill AD, El-Shirbiny AM et al (1998) Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186:423-427
34. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000: the global picture. Eur J Cancer 37(Suppl 8):S4-S66
35. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, v2002. CA Cancer J Clin 55:74-108
36. Pijpers R, Meijer S, Hoekstra OS et al (1997) Impact of lymphoscintigraphy on sentinel node identification with technetium-99 m-colloidal albumin in breast cancer. J Nucl Med 38:366-368
37. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23(19):4312-4321
38. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E, Sedlmayer F et al (2003) Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. World J Surg 27(12):1291-1294
39. Rouviere H (1938) Anatomy of the human lymphatic system: a compendium. Edwards Brothers, Ann Arbor
40. Sappey MPC (1834) Injection Preparation et Conservation des Vais-Seaux Lyphatics (thes pour le doctorat en medecine, No. 241). Rignoux Imprimeur de la Faculte de Medecine, Paris
41. Spratt J, Tobin G (1995) Gross anatomy of the breast. In: Donegan W, Spratt J (eds) Cancer of the breast. WB Saunders, Philadelphia, pp 37-42
42. Turner-Warwick RT (1959) The lymphatics of the breast. Br J Surg 46:574-582
43. Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867
44. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Cerrito PB, McMasters KM (2001) Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 192(6):684-689